These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24699210)

  • 1. The social value of mortality risk reduction: VSL versus the social welfare function approach.
    Adler MD; Hammitt JK; Treich N
    J Health Econ; 2014 May; 35():82-93. PubMed ID: 24699210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention, treatment, and palliative care: The relative value of health improvements under alternative evaluation frameworks.
    Hammitt JK
    J Health Econ; 2022 Jul; 84():102643. PubMed ID: 35688094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring social welfare functions and violation of monotonicity: an example from inequalities in health.
    Abasolo I; Tsuchiya A
    J Health Econ; 2004 Mar; 23(2):313-29; discussion 332-4. PubMed ID: 15019757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fair innings? The utilitarian and prioritarian value of risk reduction over a whole lifetime.
    Adler MD; Ferranna M; Hammitt JK; Treich N
    J Health Econ; 2021 Jan; 75():102412. PubMed ID: 33373936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-social welfare functions: a reply to Hansen et al.
    Edlin R
    J Health Econ; 2004 Sep; 23(5):899-905. PubMed ID: 15353185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the (Near) Equivalence of Welfarist and Extra-Welfarist Methods to Value Healthcare With Implications for Assessing Equity.
    Phelps CE
    Value Health; 2023 Nov; 26(11):1601-1607. PubMed ID: 37597613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring the social importance of concentration or dispersion of individual health benefits.
    Rodríguez-Míguez E; Pinto-Prades JL
    Health Econ; 2002 Jan; 11(1):43-53. PubMed ID: 11788981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of a statistical life in road safety: a benefit-transfer function with risk-analysis guidance based on developing country data.
    Milligan C; Kopp A; Dahdah S; Montufar J
    Accid Anal Prev; 2014 Oct; 71():236-47. PubMed ID: 24952315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of a statistical life in Sweden: a review of the empirical literature.
    Hultkrantz L; Svensson M
    Health Policy; 2012 Dec; 108(2-3):302-10. PubMed ID: 23084655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the possibility of a bridge between CBA and CEA: comments on a paper by Dolan and Edlin.
    Hansen BO; Hougaard JL; Keiding H; Østerdal LP
    J Health Econ; 2004 Sep; 23(5):887-98. PubMed ID: 15353184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valuing the benefits and costs of health care programmes: where's the 'extra' in extra-welfarism?
    Birch S; Donaldson C
    Soc Sci Med; 2003 Mar; 56(5):1121-33. PubMed ID: 12593883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating sign-dependence in health-related social welfare functions.
    Attema AE
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):223-8. PubMed ID: 25543906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of a statistical life: a meta-analysis with a mixed effects regression model.
    Bellavance F; Dionne G; Lebeau M
    J Health Econ; 2009 Mar; 28(2):444-64. PubMed ID: 19100640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are estimates of the value of a statistical life exaggerated?
    Doucouliagos C; Stanley TD; Giles M
    J Health Econ; 2012 Jan; 31(1):197-206. PubMed ID: 22079490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age effects in monetary valuation of reduced mortality risks: the relevance of age-specific hazard rates.
    Leiter AM
    Eur J Health Econ; 2011 Aug; 12(4):331-44. PubMed ID: 20376521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age effects in mortality risk valuation.
    Brey R; Pinto-Prades JL
    Eur J Health Econ; 2017 Sep; 18(7):921-932. PubMed ID: 27928743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review to Update 'Value of a Statistical Life' Estimates for Australia.
    Ananthapavan J; Moodie M; Milat AJ; Carter R
    Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34200344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valuing life: a plea for disaggregation.
    Sunstein CR
    Duke Law J; 2004 Nov; 54(2):385-445. PubMed ID: 15940845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valuing mortality risk reductions from environmental, transport, and health policies: a global meta-analysis of stated preference studies.
    Lindhjem H; Navrud S; Braathen NA; Biausque V
    Risk Anal; 2011 Sep; 31(9):1381-407. PubMed ID: 21957946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing whether there is a cancer premium for the value of a statistical life.
    Viscusi WK; Huber J; Bell J
    Health Econ; 2014 Apr; 23(4):384-96. PubMed ID: 23520055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.